Categories: DiagnosticsDNANews

Applied DNA to Report Third Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, August 10, 2023

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

STONY BROOK, NY / ACCESSWIRE / August 7, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release financial results for the three months ended June 30, 2023 after the market close on Thursday, August 10, 2023. The Company will host a conference call for the investment community to discuss the results and answer questions at 4:30 p.m. ET.

Date & Time: Thursday, August 10 @ 4:30 p.m. ET

Dial In:

A replay of the conference call will be available for 7 days following the conclusion of the call:

  • Replay for domestic callers (toll free): 877-344-7529, replay access code 8409849
  • Replay for international callers: 855-669-9658, replay access code 8409849

An accompanying slide presentation will be embedded in the webcast (live and replay) and can also be accessed in the ‘Company Events‘ section under the ‘News & Events’ tab of the Applied DNA website at https://investors.adnas.com/. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

About Applied DNA Sciences

Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid (“DNA”). Using the polymerase chain reaction (“PCR”) to enable both the production and detection of DNA, we operate in three primary business markets: (i) the manufacture of DNA for use in nucleic acid-based therapeutics; (ii) the detection of DNA in molecular diagnostics testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under the ticker symbol ‘APDN,’ and its publicly traded warrants are listed on OTC under the ticker symbol ‘APPDW.’

For additional information:

Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: www.adnas.com
Twitter: @APDN

SOURCE: Applied DNA Sciences

View source version on accesswire.com:
https://www.accesswire.com/772642/Applied-DNA-to-Report-Third-Quarter-Fiscal-2023-Financial-Results-and-Host-Investor-Conference-Call-and-Webcast-on-Thursday-August-10-2023

Staff

Recent Posts

HCP OneHealthPort Appoints New Director of External Affairs to Strengthen Strategic Partnerships and Community Engagement

SAMMAMISH, Wash., May 19, 2025 /PRNewswire/ -- HCP OneHealthPort, Washington state's leading nonprofit health data utility,…

5 hours ago

CareConnect Announces New Partnership and ATS Integration with myCNAjobs to Bolster Hiring Solution

PORT WASHINGTON, N.Y., May 19, 2025 /PRNewswire/ -- CareConnect, LLC, a leader in homecare AI,…

5 hours ago

eCOA Solutions Market worth US$4.78 billion by 2030 with 16.1% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., May 19, 2025 /PRNewswire/ -- The global eCOA solution market, valued at US$1.94…

5 hours ago

Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition

Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering AI-powered breast cancer…

5 hours ago